JLB & Associates Inc. Lowers Holdings in Maximus, Inc. (NYSE:MMS)

JLB & Associates Inc. decreased its holdings in Maximus, Inc. (NYSE:MMS) by 7.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,378 shares of the health services provider’s stock after selling 588 shares during the quarter. JLB & Associates Inc.’s holdings in Maximus were worth $551,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Van Berkom & Associates Inc. raised its holdings in shares of Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after acquiring an additional 98,264 shares during the last quarter. Handelsbanken Fonder AB increased its holdings in shares of Maximus by 14.1% in the fourth quarter. Handelsbanken Fonder AB now owns 15,416 shares of the health services provider’s stock valued at $1,151,000 after purchasing an additional 1,900 shares during the last quarter. Ieq Capital LLC acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $541,000. Bryn Mawr Capital Management LLC increased its holdings in shares of Maximus by 290.3% in the fourth quarter. Bryn Mawr Capital Management LLC now owns 8,400 shares of the health services provider’s stock valued at $627,000 after purchasing an additional 6,248 shares during the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of Maximus by 1.1% in the fourth quarter. Principal Financial Group Inc. now owns 165,781 shares of the health services provider’s stock valued at $12,376,000 after purchasing an additional 1,738 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Trading Down 2.2 %

MMS opened at $66.80 on Friday. Maximus, Inc. has a 52 week low of $65.79 and a 52 week high of $93.97. The business has a fifty day simple moving average of $73.87 and a 200-day simple moving average of $81.87. The firm has a market cap of $3.78 billion, a P/E ratio of 14.36 and a beta of 0.72. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. Maximus’s dividend payout ratio is currently 25.81%.

Insider Transactions at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders bought a total of 7,063 shares of company stock worth $502,017 over the last ninety days. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.